(Gedivumab)Biosimilar Reference Antibody-GS40297 新品

货号：GS40297

Gedivumab is an investigational fully human neutralizing monoclonal antibody developed for the prevention and/or treatment of influenza A virus infection. As a fully human antibody, it is designed to minimize immunogenicity in patients. It functions by binding with high affinity to a specific, conserved epitope on the surface of the influenza A virus. This binding neutralizes the virus, meaning it blocks the virus's ability to attach to and enter human respiratory cells, thereby preventing infection and halting viral replication in already infected individuals.